ArticleCancers2022

Inhibitors of the Actin-Bundling Protein Fascin-1 Developed for Tumor Therapy Attenuate the T-Cell Stimulatory Properties of Dendritic Cells.

Yanira Zeyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.